Keyword search

Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).

Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.

Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.

Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.

Description: Cardiovascular health measures of the household population, by sex and age group.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.

Description:

The Cancer Survival Statistics tables provide site-specific five-year observed and relative survival estimates for cases diagnosed from 1992 onwards. In addition to age-specific and age-standardized national (excl. Quebec) estimates, all ages (15 to 99 years) and age-standardized provincial estimates are available.

Description:

The annual Cancer Incidence in Canada tables provide information on the number of new cases and rates of cancer tumours and patients from 1992 onwards by five-year age-groups and sex for all Canadian provinces and territories as well as information on the primary ICD-O-3 sites of cancer.

Description:

The Cancer Survival Statistics tables provide site-specific five-year observed and relative survival estimates for cases diagnosed from 1992 onwards (colorectal, lung, prostate and female breast cancer cases only). In addition to age-specific and age-standardized national (excl. Quebec) estimates, all ages (15 to 99 years) and age-standardized provincial estimates are available.

Description: Body mass index (BMI), Canadian standard, by age group and sex, household population aged 20 to 64 excluding pregnant women, territories.

Description: Body mass index (BMI), International standard, by age group and sex, household population aged 20 to 64 excluding pregnant women, territories.

Description:

The special ten year anniversary edition of Canadian cancer statistics 1997 represents a collaborative effort between Statistics Canada, the National Cancer Institute of Canada, Health Canada, the Canadian Cancer Society, and provincial/territorial cancer registries. This 71 page monograph contains estimates of cancer incidence and mortality for 1997, historical (actual and estimated) data from 1969 to 1997, and selected indicators on the burden of cancer. Estimates were produced by modelling actual cancer incidence and mortality data by province for selected cancer sites. The special topic this year is a comparison of the burden of cancer in Canada in 1997 to that reported in the first edition in 1987.

Description: Certain population groups face a disproportionate burden of exposure to COVID-19. This study examined characteristics of Canadians living in private households in fall 2020 and winter 2021 who had been infected with COVID-19.

Description:

This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.

Description: Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description:

This document provides descriptive results of the muscle and bone density of the tibia. Descriptive results for lower limb muscle power and force are also presented.

Description:

Hypertension is a common condition experienced by close to one-quarter of the adult population in Canada. There is evidence that this condition or the medications used to treat it may lead to hearing health problems. The purpose of this study is to quantify associations between hypertension and hearing health problems—defined as having hearing loss, tinnitus or both conditions for adults aged 19 to 79 years. Data from cycles 3 (2012 to 2013) and 4 (2014 to 2015) of the Canadian Health Measures Survey are used.

Description:

This infographic provides information on the prevalence of hearing loss, tinnitus, or both conditions among Canadian adults. The prevalence of each condition is presented by sex and age group. Also included is the proportion who are unaware of their hearing loss.

Description:

This study is the first comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada. The results span the complete time period of the Canadian Cancer Registry and are unaffected by changes in the age, sex and case-mix of cancers over this time. Specifically, predicted Canadian net cancer survival index (CSI) estimates for the three-year period from 2015 to 2017 are presented and compared with corresponding actual estimates dating as far back as the 1992-to-1994 period. Comparisons are made for both sexes combined and for males and females separately. Further insight is provided by the determination of the most influential cancer and sex combinations and the leading cancer types within each sex, in regard to changes in the CSI since the periods of 1992 to 1994 and 2005 to 2007.

Description:

Cancer incidence rates have been shown to vary by ethnicity, and the increasing awareness of and interest in reporting ethnic health inequalities have been growing internationally. The objective of this study was to assess cancer incidence and mortality rates by ethnicity in Canada. The study used the 2006 Canadian Census Health and Environment Cohort, linked to the Canadian Cancer Registry and the Canadian Vital Statistics-Death Database, to determine cancer cases and mortality from 2006 to 2016. Ethnicity was categorized as non-Indigenous North American (NINA); European; Caribbean; Latin, Central and South American (LCSA); African; East Asian; South Asian; and West Central Asian and Middle Eastern.

Description:

With data from the 2019 Canadian Community Health Survey, this study assessed the use of and exposure to handheld laser devices by Canadians and the potential associated health risks. In addition to the prevalence of handheld laser exposure or use, the frequency and type of injury sustained, and whether the injury was the result of personal use or someone else's use, the study also determined the type of handheld laser device being used and where the device was obtained.

Description: The data contain detailed confirmed cases of coronavirus disease (COVID-19) in Canada, which is compiled by the Public Health Agency of Canada, with the contribution from provincial and territorial Health ministries.